The Subcommittee on Oversight and Investigations opened a hearing titled "Examining Biosecurity at the Intersection of AI and Biology" to probe risks and oversight gaps as advanced AI tools accelerate biological design and experimentation. The chair emphasized both the medical promise of AI-enabled biotech and national security concerns, citing affordability of CRISPR kits and studies showing AI-generated biological designs.